Skolkovo Partners With I-Campus in China

On 7 September 2019, in partnership with the Wuxi Government, AstraZeneca celebrated the official opening of the Wuxi International Life Science Innovation Campus (I·Campus) and marked the signing of the first partners. Among them is the Skolkovo Institute for Science and Technology. 

Situated in the Wuxi National High-tech District in Jiangsu, China, I·Campus brings together innovative drug, device, diagnosis and digital companies, government, and medical and academic institutions via an open collaboration platform, helping to accelerate healthcare innovation and sciences in China. These areas are also important for Skolkovo's Biomedical Cluster.

The partnership agreement between Skolkovo and I·Campus provides for the exchange of knowledge and collaboration in biomedical sciences including, among other things, joint acceleration and go-to-market programs for Skolkovo residents, consulting and strategy programs for Russian technology companies in China, and a soft-landing program for Chinese companies in Skolkovo.

Solutions from Skolkovo were also featured on AstraZeneca's stand at the World IoT Main Summit, which was held in Wuxi on the same day. Among them were Brainbit, a non-invasive glucometer, and Botkin.AI, a medical imaging recognition system. Both generated significant interest from visitors.


12 september 2019